| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communications |
Background: Fructooligosaccharides have been claimed to lower fasting glycemia and serum total cholesterol concentrations, possibly via effects of short-chain fatty acids produced during fermentation.
Objective: We studied the effects of fructooligosaccharides on blood glucose, serum lipids, and serum acetate in 20 patients with type 2 diabetes.
Design: In a randomized, single-blind, crossover design, patients consumed either glucose as a placebo (4 g/d) or fructooligosaccharides (15 g/d) for 20 d each. Average daily intakes of energy, macronutrients, and dietary fiber were similar with both treatments.
Results: Compliance, expressed as the proportion of supplements not returned, was near 100% during both treatments. Fructooligosaccharides did not significantly affect fasting concentrations (mmol/L) of serum total cholesterol (95% CI: -0.07, 0.48), HDL cholesterol (-0.04, 0.04), LDL cholesterol (-0.06, 0.34), serum triacylglycerols (-0.21, 0.44), serum free fatty acids (-0.08, 0.04), serum acetate (-0.01, 0.01), or blood glucose (-0.37, 0.40).
Conclusions: We conclude that 20 d of dietary supplementation with fructooligosaccharides had no major effect on blood glucose, serum lipids, or serum acetate in patients with type 2 diabetes. This lack of effect was not due to changes in dietary intake, insufficient statistical power, or noncompliance of the patients.
Key Words: Fructooligosaccharides • serum cholesterol • serum triacylglycerol • serum acetate • blood glucose • type 2 diabetes • Netherlands • adults • humans
This article has been cited by other articles:
|
|
 |
|
  F. Brighenti Dietary Fructans and Serum Triacylglycerols: A Meta-Analysis of Randomized Controlled Trials J. Nutr., November 1, 2007; 137(11): 2552S - 2556S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Letexier, F. Diraison, and M. Beylot Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans Am. J. Clinical Nutrition, March 1, 2003; 77(3): 559 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Duggan, J. Gannon, and W A. Walker Protective nutrients and functional foods for the gastrointestinal tract Am. J. Clinical Nutrition, May 1, 2002; 75(5): 789 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Diabetes Care, January 1, 2002; 25(1): 148 - 198. [Full Text] [PDF]
|
|
|
|
|
|
N. M Delzenne and N. Kok Effects of fructans-type prebiotics on lipid metabolism Am. J. Clinical Nutrition, February 1, 2001; 73(2): 456S - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Luo, M. Van Yperselle, S. W. Rizkalla, F. Rossi, F. R. J. Bornet, and G. Slama Chronic Consumption of Short-Chain Fructooligosaccharides Does Not Affect Basal Hepatic Glucose Production or Insulin Resistance in Type 2 Diabetics J. Nutr., June 1, 2000; 130(6): 1572 - 1577. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Daubioul, H. S. Taper, L. D. De Wispelaere, and N. M. Delzenne Dietary Oligofructose Lessens Hepatic Steatosis, but Does Not Prevent Hypertriglyceridemia in Obese Zucker Rats J. Nutr., May 1, 2000; 130(5): 1314 - 1319. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
